NTES — NETEASE INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying NTES?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their NTES position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime). 1 congressional purchase, 0 sales disclosed in the last 6 months.
- +4 tracked investors reported holding NTES at their latest filing
- +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
- −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About NETEASE INC (NTES)
NETEASE INC (NTES) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $128M. Across recent filings, tracked investors recorded 6 new positions, 4 increased, 4 reduced, and 5 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in NTES
How many top investors track NTES
A small number of top investors own this.
NTES Ownership Composition
How NETEASE INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant95.5%
- Macro4.5%
Tracked investors currently reporting NTES
2 tracked investors have since exited this position — listed separately below.
- Izzy EnglanderJun 30, 2026Millennium ManagementShares460.2KValue$59M% Portfolio0.02%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares296.2KValue$38M% Portfolio0.04%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares210.6KValue$27M% Portfolio0.00%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares45.5KValue$5.8M% Portfolio0.01%
Previously held NTES
These investors reported NTES in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Philippe Laffont | Coatue Management | 94.3K | $8.8M | Sep 30, 2024 |
| Howard Marks | Oaktree Capital Management | 399.7K | $35.7M | Dec 31, 2024 |
Recent activity
- New$21.7MNov 14, 2024
- Increased$35.7M(71.84%)Feb 12, 2025
- Sold$0(-100.00%)May 15, 2025
- New$13KNov 14, 2025
- Reduced$10.1K(-14.45%)Feb 17, 2026
- Reduced$8.3M(-83.16%)Nov 14, 2024
- Increased$12.1M(53.03%)Feb 14, 2025
- Reduced$10M(-28.47%)Jul 21, 2025
- Increased$19.1M(46.58%)Aug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- Reduced$10.8M(-81.52%)May 15, 2024
- Sold$0(-100.00%)Aug 14, 2024
- $8.8MNov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- Increased$535.2K(26.64%)Aug 14, 2024
- Sold$0(-100.00%)Nov 14, 2024
- $52.5MFeb 14, 2024
- New$50.2MSep 16, 2024
- $457.5KMay 15, 2024
Frequently asked questions
- How many institutional investors hold NTES?
- 4 tracked institutional investors disclosed a position in NTES (NETEASE INC) in their most recent 13F filing.
- Who is the largest institutional holder of NTES?
- Izzy Englander, Millennium Management, holds the largest disclosed position in NTES, valued at $128M.
- Did institutional ownership of NTES increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 4 increased, 4 reduced, and 5 fully exited NTES.
- Where does this NTES ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.